Preventing Cognitive Decline With Metformin

Summary

Preventing Cognitive Decline With Metformin is a clinical trial^[1].

Key Facts

• Preventing Cognitive Decline With Metformin is in the country of Australia^[2].
• Preventing Cognitive Decline With Metformin's instance of is recorded as clinical trial^[3].
• Preventing Cognitive Decline With Metformin's start time is recorded as +2022-02-15T00:00:00Z^[4].
• Preventing Cognitive Decline With Metformin's end time is recorded as +2027-12-31T00:00:00Z^[5].
• Preventing Cognitive Decline With Metformin's main subject is recorded as cognitive dysfunction^[6].
• Preventing Cognitive Decline With Metformin's number of participants is recorded as {'unit': '1', 'amount': '+242'}^[7].
• Preventing Cognitive Decline With Metformin's title is recorded as Preventing Cognitive Decline With Metformin:: The MetMemory Study^[8].
• Preventing Cognitive Decline With Metformin's short name is recorded as MetMemory^[9].
• Preventing Cognitive Decline With Metformin's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}^[10].
• Preventing Cognitive Decline With Metformin's ClinicalTrials.gov ID is recorded as NCT04511416^[11].
• Preventing Cognitive Decline With Metformin's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}^[12].
• Preventing Cognitive Decline With Metformin's research intervention is recorded as metformin^[13].
• Preventing Cognitive Decline With Metformin's clinical trial phase is recorded as phase III clinical trial^[14].
• Preventing Cognitive Decline With Metformin's research subject recruitment status is recorded as recruiting^[15].
• Preventing Cognitive Decline With Metformin's study type is recorded as interventional study^[16].